Sanofi And GSK Launch Trial For COVID-19 Protein-based Vaccine

French drugmaker Sanofi and its British peer GSK have started a clinical trial for a proteinbased COVID19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.

from Top Business News- News18.com https://ift.tt/34Zs27P

• Tweet
• Share
• Share
• Share
• Share